Bafna Pharmaceuticals (BAFNAPH) Stock Overview

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company provides delayed and sustained release, chewable, and orally disintegrating tablets. It also exports its products. The company was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited operates as a subsidiary of SRJR Lifesciences LLP.

BAFNAPH Stock Information

Symbol

BAFNAPH

Address

Bafna TowersChennai, 600001India

Founded

Trading hours

Website

https://www.bafnapharma.com

Country

🇮🇳 India

Phone Number

91 44 4267 7555

Bafna Pharmaceuticals (BAFNAPH) Price Chart

Bafna Pharmaceuticals Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.9695514587678363	N/A
Market Cap	$22.94M	N/A
Shares Outstanding	23.66M	0.00%
Employees	588.00	N/A
Shareholder Equity	734.55M	18.54%

Valuation	2023	Change
P/E Ratio	0.20	N/A
P/S Ratio	1.67	N/A
P/B Ratio	0.03	N/A

Growth	2023	Change
Return on Equity	0.0018	N/A

Earnings	2023	Change
Revenue	$13.75M	N/A
Earnings	$1.35M	N/A
EPS	4.79	N/A
Earnings Yield	4.94	N/A
Gross Margin	0.336	N/A
Operating Margin	0.1046	N/A
Net income margin	0.0983	N/A

Financial Strength	2023	Change
Total Assets	$15.45M	N/A
Total Debt	$2.73M	N/A
Cash on Hand	$794.25K	N/A
Debt to Equity	0.0091	68.01%
Cash to Debt	0.2906	16468.32%
Current Ratio	$1.88	-18.72%